Second M 3 muscarinic receptor binding site contributes to bronchoprotection by tiotropium-Reference-Cited by-同舟云学术

Second M 3 muscarinic receptor binding site contributes to bronchoprotection by tiotropium

Published:2019-07-02 Issue:16 Volume:176 Page:2864-2876
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Kistemaker Loes E.M.¹²^ORCID,Elzinga Carolina R.S.¹²,Tautermann Christofer S.³,Pieper Michael P.⁴,Seeliger Daniel³,Alikhil Suraya¹²,Schmidt Martina¹²,Meurs Herman¹²,Gosens Reinoud¹²

Affiliation:

1. Department of Molecular PharmacologyUniversity of Groningen Groningen The Netherlands

2. Groningen Research Institute for Asthma and COPD, University Medical Center GroningenUniversity of Groningen Groningen The Netherlands

3. Department of Medicinal ChemistryBoehringer Ingelheim Pharma GmbH & Co. KG Biberach an der Riss Germany

4. Immunology and Respiratory Disease ResearchBoehringer Ingelheim Pharma GmbH & Co. KG Biberach an der Riss Germany

Funder

Boehringer Ingelheim

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14707

Reference41 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors

2. SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

3. Dual bronchodilation with QVA149versussingle bronchodilator therapy: the SHINE study

4. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease

5. Cholinergic Pathways in the Lungs and Anticholinergic Therapy for Chronic Obstructive Pulmonary Disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deepening insights into cholinergic agents for intraocular pressure reduction: systems genetics, molecular modeling, and in vivo perspectives;Frontiers in Molecular Biosciences;2024-07-26

2. Potency, dissociation kinetics and reversibility of fentanyls and nitazenes by naloxone at the μ opioid receptor;2024-06-05

3. Opioid ligands may act by blocking the muscarinic anti-inflammatory effect through allostericity in M1 receptors;Medical Hypotheses;2023-11

4. Unbinding Kinetics of Muscarinic M3 Receptor Antagonists Explained by Metadynamics Simulations;Journal of Chemical Information and Modeling;2023-04-13

5. Bronchodilators for Airway Disease;Encyclopedia of Respiratory Medicine;2022